Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus

Applied and Environmental Microbiology

Volumn 79, Issue 6, 2013, Pages 1835-1842

  MacPhee, Roderick A ^a,b   Miller, Wayne L ^a   Gloor, Gregory B ^b   McCormick, John K ^a,b   Hammond, Jo Anne ^a,b   Burton, Jeremy P ^a,b   Reid, Gregor ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL SAMPLES; ENTEROCOCCUS SPP; IN-VITRO; LACTOBACILLUS SPP; MICROBIOTAS; PATHOGENIC BACTERIUM; PRODUCTION OF; RISK FACTORS; S. AUREUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TOXIC SHOCKS; TOXIN PRODUCTION;

BACILLI;

TOXIC MATERIALS;

BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; SUPERANTIGEN;

BACTERIUM; DISEASE TREATMENT; INFECTIOUS DISEASE; INFECTIVITY; PATHOGEN; RISK FACTOR; TOXIN; VIRULENCE; WOMENS HEALTH;

ARTICLE; BIOSYNTHESIS; ENTEROCOCCUS; FEMALE; HUMAN; LACTOBACILLUS; METABOLISM; METAGENOME; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; VAGINA; VAGINITIS;

BACTERIAL TOXINS; ENTEROCOCCUS; ENTEROTOXINS; FEMALE; HUMANS; LACTOBACILLUS; METAGENOME; MICROBIAL INTERACTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; SUPERANTIGENS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84874806255     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02908-12     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. 2011. Summary of notifiable diseases-United States, 2009. MMWR Morb. Mortal. Wkly. Rep. 58:1-100.
2. Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Harwell J, Lefkowitz LK, Makintubee S, Cundiff DR, Sitze S, Toxic Shock Syndrome Study Group. 1989. Active surveillance for toxic shock syndrome in the United States, 1986. Rev. Infect. Dis. 11(Suppl 1):S28-S34.
3. Davis CC, Kremer MJ, Schlievert PM, Squier CA. 2003. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189:1785-1791.
4. Schlievert PM, Jablonski LM, Roggiani M, Sadler I, Callantine S, Mitchell DT, Ohlendorf DH, Bohach GA. 2000. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect. Immun. 68:3630-3634.
5. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD, Fraser DW. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436-1442.
6. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol. Gen. Genet. 202:58-61.
7. Novick RP, Geisinger E. 2008. Quorum sensing in staphylococci. Annu. Rev. Genet. 42:541-564.
8. Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ. 2001. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183:7341-7353.
9. Chien Y, Cheung AL. 1998. Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus. J. Biol. Chem. 273:2645- 2652.
10. Andrey DO, Renzoni A, Monod A, Lew DP, Cheung AL, Kelley WL. 2010. Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA. J. Bacteriol. 192:6077- 6085.
11. Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N. 2003. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol. Lett. 223:167-175.
12. Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, Gentry DR. 1999. Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus. Infect. Immun. 67:3667-3669.
13. Yarwood JM, Schlievert PM. 2000. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J. Clin. Microbiol. 38:1797-1803.
14. Sarafian SK, Morse SA. 1987. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J. Med. Microbiol. 24:75- 81.
15. Wong AC, Bergdoll MS. 1990. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect. Immun. 58:1026-1029.
16. Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, Romero R. 2011. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 118: 533-549.
17. Voravuthikunchai SP, Bilasoi S, Supamala O. 2006. Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe 12: 221-226.
18. Otero MC, Nader-Macías ME. 2006. Inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle. Anim. Reprod. Sci. 96:35- 46.
19. Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. 2011. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. U. S. A. 108:3360-3365.
20. Fredricks DN, Fiedler TL, Marrazzo JM. 2005. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353:1899- 1911.
21. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, Reid G. 2010. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5:e12078. doi:10.1371/journal.pone.0012078.
22. Holst E, Goffeng AR, Andersch B. 1994. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J. Clin. Microbiol. 32:176-186.
23. Gomez LM, Sammel MD, Appleby DH, Elovitz MA, Baldwin DA, Jeffcoat MK, Macones GA, Parry S. 2010. Evidence of a geneenvironment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am. J. Obstet. Gynecol. 202:386.e1- 386.e6. doi:10.1016/j.ajog.2010.01.042.
24. Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, Rice P, Richter HE. 2005. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am. J. Epidemiol. 162:585-590.
25. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109:34-43.
26. Carey JC, Klebanoff MA. 2005. Is a change in the vaginal flora associated with an increased risk of preterm birth? Am. J. Obstet. Gynecol. 192:1341- 1346.
27. Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S. 2009. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116:1315-1324.
28. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. 1994. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 308:295-298.
29. Rezeberga D, Lazdane G, Kroica J, Sokolova L, Donders GG. 2008. Placental histological inflammation and reproductive tract infections in a low risk pregnant population in Latvia. Acta Obstet. Gynecol. Scand. 87: 360-365.
30. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29:297-301.
31. Gloor GB, Hummelen R, Macklaim JM, Dickson RJ, Fernandes AD, MacPhee R, Reid G. 2010. Microbiome profiling by Illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One 5:e15406. doi:10.1371/journal.pone.0015406.
32. Mesak LR, Yim G, Davies J. 2009. Improved lux reporters for use in Staphylococcus aureus. Plasmid 61:182-187.
33. Schlievert PM, Blomster DA. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236-242.
34. Carson HJ, Lapoint PG, Monif GR. 1997. Interrelationships within the bacterial flora of the female genital tract. Infect. Dis. Obstet. Gynecol. 5:303-309.
35. Chaisilwattana P, Monif GR. 1995. In vitro ability of the group B streptococci to inhibit gram-positive and gram-variable constituents of the bacterial flora of the female genital tract. Infect. Dis. Obstet. Gynecol. 3:91-97.
36. Monif GR. 1999. Semiquantitative bacterial observations with group B streptococcal vulvovaginitis. Infect. Dis. Obstet. Gynecol. 7:227-229.
37. Chen KT, Huard RC, Della-Latta P, Saiman L. 2006. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet. Gynecol. 108(3 Pt 1):482- 487.
38. Zárate G, Nader-Macias ME. 2006. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett. Appl. Microbiol. 43:174-180.
39. Laughton JM, Devillard E, Heinrichs DE, Reid G, McCormick JK. 2006. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology 152(Pt 4):1155- 1167.
40. Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. 2010. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J. Clin. Microbiol. 48:1812-1819.